(Q35583575)

9 August 2017

1 reference

title

Helicobacter pylori and nonmalignant diseases (English)

1 reference

9 August 2017

1 reference

2

Peter Malfertheiner

1 reference

9 August 2017

Vassili Isakov

1

1 reference

9 August 2017

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

8 Suppl 1

1 reference

9 August 2017

page(s)

36-43

1 reference

Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Review article: Helicobacter pylori infection and gastric outlet obstruction - prevalence of the infection and role of antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Does Helicobacter pylori eradication reduce the long-term requirements for acid suppressants in patients with a history of peptic ulcer disease in general practice? Results from a four-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Helicobacter pylori does not play a part in the dyspeptic complaints of rheumatology patients receiving long term treatment with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Helicobacter pylori infection treatment of nonulcer dyspepsia: an analysis of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infection. A 6- to 7-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Reflux esophagitis facilitates low Helicobacter pylori infection rate and gastric inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Impact of Helicobacter pylori eradication on heartburn in patients with gastric or duodenal ulcer disease -- results from a randomized trial programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Carditis is associated with Helicobacter pylori-induced gastritis and not reflux esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Inflammation and intestinal metaplasia at the squamocolumnar junction in young patients with or without Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Empirical prescribing for dyspepsia: randomised controlled trial of test and treat versus omeprazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Empirical treatment based on "typical" reflux symptoms is inappropriate in a population with a high prevalence of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Relationship between non-steroidal anti-inflammatory drug use and Helicobacter pylori infection in bleeding or uncomplicated peptic ulcers: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Relationship of sliding hiatus hernia to gastroesophageal reflux disease: a possible role for Helicobacter pylori infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Helicobacter pylori-induced duodenal ulcer frequently coincides with gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1523-5378.2003.00169.X

Initial management strategies for dyspepsia

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001961

Eradication of Helicobacter pylori for non-ulcer dyspepsia

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002096

Identifiers

DOI

10.1046/J.1523-5378.2003.00169.X

1 reference

9 August 2017

1 reference